1004 – Maintenence Treatment with Mirikizumab, a...

Gastroenterology 2019 / 05 Vol. 156; Iss. 6

1004 – Maintenence Treatment with Mirikizumab, a P19-Directed Il-23 Antibody: 52-Week Results in Patients with Moderately-Toseverely Active Ulcerative Colitis

D'Haens, Geert R., Sandborn, William J., Ferrante, Marc, Bhandari, Bal R., Berliba, Elina, Hibi, Toshifumi, Tuttle, Jay, Friedrich, Stuart, Durante, Michael, Arora, Vipin, Feagan, Brian G., Canavan, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
156
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(19)37336-6
Date:
May, 2019
File:
PDF, 2.21 MB
2019
Conversion to is in progress
Conversion to is failed